Animal Health Market Forecast to Grow at 4.9% CAGR, Reaching USD 239 Billion by 2032
The global animal health market is expected to reach a value of USD 239 billion by 2032, up from USD 150 billion in 2022, growing at a compound annual growth rate (CAGR) of 4.9% from 2022 to 2032. This growth is driven by several factors, including the rising pet adoption rates and the increasing demand for livestock products to meet global food security needs. Additionally, advancements in veterinary technology, such as digital radiographs and improved diagnostics, contribute significantly to market expansion.
Despite these growth drivers, the market faces challenges, including the high costs associated with veterinary care and diagnostics, which can range from USD 50 to USD 250 for a standard check-up and up to USD 1,500 for comprehensive veterinary treatment. Furthermore, there are concerns about the uniformity and accessibility of veterinary services, particularly in developing regions.
Recent developments in the market include a growing trend towards pet humanization, leading to increased expenditure on pet healthcare and insurance. Additionally, significant investments in research and development have led to innovations in veterinary pharmaceuticals and preventive care solutions. The production animal segment dominates the market, driven by concerns over food safety and sustainability, while the companion animal segment is expected to grow robustly due to the increasing pet-to-human ratio and the associated health benefits of pet ownership.
Overall, the animal health market is poised for substantial growth, driven by technological advancements, increased pet ownership, and the rising demand for effective animal healthcare solutions.
Key Takeaways
- The global animal health market is expected to grow from USD 150 billion in 2022 to USD 239 billion by 2032, at a CAGR of 4.9%.
- In 2022, the production animal segment dominated, holding over 60% revenue share, driven by food security initiatives and sustainable livestock practices.
- Pharmaceuticals led the product categories due to advancements in veterinary drugs and increased pet ownership, maintaining market dominance.
- Hospital pharmacies accounted for over 52% of the distribution channel market share in 2022, supported by frequent pet treatments.
- Veterinary hospitals and clinics were the largest end-users in 2022, providing a wide range of treatments and diagnostic services.
- North America led the regional market in 2022 with a 33.6% revenue share, driven by stringent animal welfare regulations and technological advancements.
- The Asia Pacific region is expected to grow at a 12.7% CAGR due to rising disposable incomes and increasing awareness of pet nutrition.
- Market growth drivers include rising pet adoption, increasing foodborne disease incidence, and growing demand for transparency in natural products.
- Challenges include rising veterinary service costs, potentially slowing market growth as financial burdens increase for pet owners.
- Opportunities are expanding with increased pet life expectancy, promoting advancements in early wellness and elder care treatments in veterinary services.
Get Sample PDF Report: https://market.us/report/animal-health-market/request-sample/
Animal Health Market Key Segments
By Animal Type
- Production
- Companion
By Product
- Feed Additives
- Vaccines
- Pharmaceuticals
By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- E-commerce
- Others
By End-User
- Veterinary Hospitals and Clinics
- Animal Care and Rehabilitation Centres
- Diagnostic Centres
- Other End-Users
Key Regions
- North America (The US, Canada, Mexico)
- Western Europe (Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, Rest of Western Europe)
- Eastern Europe (Russia, Poland, The Czech Republic, Greece, Rest of Eastern Europe)
- APAC (China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Rest of APAC)
- Latin America (Brazil, Colombia, Chile, Argentina, Costa Rica, Rest of Latin America)
- Middle East & Africa (Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, Rest of MEA)
Buy Directly: https://market.us/purchase-report/?report_id=96947
Key Players Analysis
Merck Animal Health is a global leader in the animal health sector, offering a diverse range of veterinary medicines and services. The company is known for its innovative product portfolio, which includes vaccines, pharmaceuticals, and biologics designed to prevent, treat, and control diseases across various animal species. With a presence in over 50 countries and marketing its products in more than 140 countries, Merck Animal Health emphasizes high-quality, scientifically-proven solutions. The company’s commitment to customer satisfaction, quality, and integrity has made it a trusted partner for veterinarians and animal owners worldwide.
Ceva Santé Animale is a prominent global player in the animal health industry, specializing in the development and distribution of vaccines, pharmaceuticals, and biological products. The company’s mission is to foster animal health and welfare by delivering innovative solutions and products for livestock and companion animals. Ceva is active in more than 110 countries, operating through a network of R&D facilities and manufacturing sites. The company’s focus on customer-centric innovation and sustainable practices positions it as a leader in enhancing animal health and productivity globally.
Vetoquinol is a family-owned business and one of the largest veterinary pharmaceutical companies globally. The company focuses on the research, development, production, and marketing of drugs and non-medicinal products for livestock and pets. Vetoquinol’s portfolio includes antibiotics, anti-inflammatories, and pain management solutions. Operating in over 100 countries, the company emphasizes innovation and collaboration with veterinarians and pet owners to improve animal health and welfare. Vetoquinol’s commitment to high-quality products and customer satisfaction drives its ongoing growth and success in the animal health sector.
Zoetis, a leading global animal health company, focuses on the discovery, development, and manufacturing of veterinary vaccines and medicines. With a robust portfolio covering livestock and companion animals, Zoetis serves veterinarians, livestock producers, and pet owners in more than 100 countries. The company’s R&D efforts are aimed at advancing animal health through innovative products and technologies. Zoetis’ commitment to high-quality standards and customer satisfaction has solidified its position as a trusted partner in the animal health industry.
Boehringer Ingelheim Animal Health is a top-tier animal health company dedicated to improving the health and well-being of animals through innovative solutions. The company’s extensive product range includes vaccines, parasiticides, and therapeutics for livestock and pets. Boehringer Ingelheim’s focus on research and development, combined with its global reach and partnerships, enables it to address complex animal health challenges. The company’s commitment to sustainable practices and customer-driven innovation helps enhance the lives of animals and the people who care for them.
Animal Health Market Key Players:
- Merck Animal Health
- Ceva Santé Animale
- Vetoquinol
- Zoetis
- Boehringer Ingelheim GmbH
- IDEXX
- Elanco
- Heska Corporation
- Virbac
- B.Braun Vet Care
- Covetrus
- DRE Veterinary
- Televet
- Mars Inc.
- Phibro Animal Health Corporation
- Dechra Pharmaceuticals PLC
- Bimeda, Inc.
- Midmark Corporation
- Thermo Fisher Scientific, Inc.
- IDVet
- Intas Pharmaceuticals Ltd.
- Other Key Players
Animal Health Market Report Scope >> Market Value (2022): USD 150 Billion || Forecast Revenue (2032): USD 239 Billion || CAGR (2023-2032): 4.9% || Base Year Estimation: 2023 || Historic Period: 2019-2022 || Forecast Period: 2024-2033.
Inquire More about report: https://market.us/report/animal-health-market/#inquiry
About Market.US
Market.US is renowned for its comprehensive market research and analysis, providing customized and syndicated reports to a global clientele. Specializing in a variety of sectors, they offer strategic insights and detailed market forecasts, assisting businesses in making informed decisions. With a focus on innovation and accuracy, Market.US supports clients in over 126 countries, and maintains a strong repeat customer rate, underscoring their commitment to quality and client satisfaction. Their team excels in delivering exceptional research services, ensuring that no detail is overlooked in any target market.
Contact Details
Market.us (Powered By Prudour Pvt. Ltd.)
Contact No: +1 718 618 4351.
Email: inquiry@market.us
Blog: https://medicalmarketreport.com/
View More Trending Reports
Disposable Endoscopes Market Projected Surge To USD 8.9 Billion By 2033, With A Steady 17.2% CAGR
Healthcare Cybersecurity Market Projected To Reach USD 93.6 Billion With 17.7% CAGR By 2033
Brachytherapy Market Will Increase USD 2159.7 Billion By 2033 And Has Guessed Around 8.2% CAGR
Disposable Syringes Market Size Set To Reach USD 30.1 Billion By 2033
Editor Details
-
Company:
- Wired Release
- Website:
